Australia's most trusted
source of pharma news
Friday, 21 November 2025
Friday, 21 November 2025
Subscribe
Login
$275 blunder opens huge market
This company's failure to pay a AUD$275 patent maintenance fee has opened up a monster market to generics giant Sandoz with its CEO quipping "I'm sure someone's lost their job".
Pharma votes for Best Workplace
ICYMI: See which company has been ranked the best place to work by pharma professionals plus the other top stories this week
TODAY Your Week in 5 Minutes
AI threat no one is talking about
Australian pharma coach is warning of a deeper disruption to the workplace than job losses if guardrails aren't put in place
TODAY
March PBAC Agenda drops early
When PBAC meets in March, 32 companies will be chasing the first recommendations for 2026
20 November
Tough times? Not for all pharmas
Overall market cap for the industry is up but it hides a dramatic difference in the results of individual pharmas
19 November
Is Australia simply not viable?
Without urgent change, this Aussie MD is warning that pharma companies will increasingly decide not to bring medicines here
18 November
Aussie Novo dodges major job cuts
Despite axing 9000 jobs, the impact locally has been limited although the exact number of Aussie jobs gone remains undisclosed
18 November
Latest Jobs
Customer Service RepresentativeSenior Payroll OfficerHead of SalesRegulatory Affairs SpecialistHead of People and CulturePharmaceutical Sales RepresentativeTM - QLD South ConsumablesCommercial Lead25 more...
Pharma in Focus Jobs
Sales & Customer Relations (14)
- Customer Service Representative - East Brisbane
- Head of Sales - Melbourne, VIC
- Pharmaceutical Sales Representative - Sydney
- Key Account Manager - Brisbane
- Clinical Sales Specialist - Sydney
- Clinical Sales Specialist - Melbourne
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Belrose
- Customer Service Representative - Belrose
- Inside Sales - Sydney
- Customer Service Representative - St Leonards
- Customer Service Representative - Macquarie Park
- Key Account Manager - Sydney
- Customer Service Representative - Macquarie Park
Clinical & Medical, R&D (4)
- Clinical Sales Specialist - Sydney
- Clinical Sales Specialist - Melbourne
- Clinical Affairs Lead - Sydney
- QC Microbiologist - Broadmeadows
Regulatory, Pharmacovigilance & QA (5)
- Regulatory Affairs Specialist - Sydney
- Senior Quality Assurance Associate - Sydney
- Senior Regulatory Affairs Associate - Sydney
- Pharmacovigilance Associate - Sydney
- Quality assurance associate - Sydney
Other (13)
- Senior Payroll Officer - Melbourne
- Head of People and Culture - Kingsgrove
- TM - QLD South Consumables - Brisbane
- Commercial Lead - Melbourne
- Senior Recruitment Consultant - Sydney
- Senior Recruitment Consultant - Sydney
- Warehouse Assistant - Macquarie Park
- People and Culture Manager - Kingsgrove
- Technical Service & Warehouse Coordinator - Alexandria
- Service Administrator - Belrose
- Warehouse & Logistics Officer - Macquarie Park
- Financial Reporting Manager - Macquarie Park
- Financial Analyst - Melbourne
Boost for multi-cancer funding
Strong results of a combination treatment across a variety of cancers highlights the need for broad cancer listings on the PBS
TODAY
Trial points to better treatment
Study reveals the potential for more precise imaging of kidney cancer cells, allowing doctors to make better treatment choices
TODAY
Best in Aussie Med Affairs gonged
Two new awards were launched at the MAPA Excellence Awards last night, which recognised six outstanding medical affairs professionals
20 November
Blooms sets blistering pace
Hits major milestone with the recycling of 20 million blister packs, keeping more than 30,000kg of aluminum and plastic out of landfill
20 November
Top drugs expanding their patch
At the first meeting for 2026, PBAC will consider 22 changes to listings, almost half to add new disease indications
20 November
Mega-drug clears hurdle for listing
With a PBAC recommendation already under its belt, the TGA approval for this next-gen treatment has cleared the way for listing
20 November
Which pharma hit AFR Fast 100?
This pharma found a niche of unmet need, and by filling it has been recognised as one of our fastest-growing companies
19 November
CSL joins US manufacturing rush
Aussie giant joins a long line of pharma companies expanding their US footprint in the wake of Donald Trump's tariff threats
19 November
J&J buys 'cancer revolution' asset
It's nowhere near the most expensive acquisition this year but this buyout could create the next generation of oral cancer treatments
19 November
Workforce crisis needs investment
New white paper launched by ARCS urges workforce system reform to keep Australia a top-tier clinical trials destination
19 November
BMS rides to fund cancer fight
Australian employees have joined a gruelling cycle across Japan to raise funds and awareness for bowel cancer
18 November
Company swoops on US$9B prize
After a rival ended a deal with a small pharma developing an antiviral biologic for flu, looks who's stepped in with a buyout offer
18 November
Telehealth rises in Australia
More HCPs and patients are seeing the value in telehealth, with a third expecting it to be their main healthcare by 2030
18 November
Most want to work at this pharma
Several thousand life sciences professionals voted for the companies they most wanted to work at. See who topped the list
17 November